Industry
Medical - Instruments & Supplies
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
March 21, 2024 | 4:54 pm
Portfolio Pulse from Benzinga Newsdesk
March 21, 2024 | 10:29 am
Portfolio Pulse from Benzinga Newsdesk
March 20, 2024 | 12:18 pm
Portfolio Pulse from Benzinga Newsdesk
March 06, 2024 | 2:02 pm
Portfolio Pulse from Benzinga Newsdesk
February 28, 2024 | 2:03 pm
Portfolio Pulse from Vandana Singh
February 21, 2024 | 5:24 pm
Portfolio Pulse from Benzinga Insights
February 19, 2024 | 9:30 pm
Portfolio Pulse from Benzinga Insights
February 08, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Insights
February 07, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Newsdesk
January 26, 2024 | 1:05 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.